Novo Nordisk A/S ADR buy TD Cowen
Start price
19.08.25
/
50%
€47.20
Target price
19.08.26
€60.08
Performance (%)
-17.46%
Price
19.06.26
€38.96
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -17.46%. This prediction currently runs until 19.08.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 2.688% | 2.688% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target lowered by analysts at TD Cowen from $105.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.00
04.12.23
04.12.23
€106.28
04.12.24
04.12.24
11.83%
05.12.24
05.12.24
